Revance Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ACLX
Arcellx, Inc. |
$56.83 | $3.11 B | -28.29 | 163 |
![]() AKRO
Akero Therapeutics, Inc. |
$35.99 | $2.87 B | -9.6 | 63 |
![]() AMLX
Amylyx Pharmaceuticals, Inc. |
$3.47 | $307.01 M | -0.78 | 123 |
![]() APLS
Apellis Pharmaceuticals, Inc. |
$19.82 | $2.49 B | -12.39 | 705 |
![]() BPMC
Blueprint Medicines Corporation |
$80.27 | $5.13 B | -75.02 | 649 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$7.02 | $711.51 M | -6.88 | 181 |
![]() DMAC
DiaMedica Therapeutics Inc. |
$3.50 | $149.78 M | -5.82 | 27 |
![]() ETNB
89bio, Inc. |
$5.49 | $801.45 M | -1.56 | 93 |
![]() IMCR
Immunocore Holdings plc |
$26.25 | $1.31 B | -25.74 | 493 |
![]() ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 |
![]() KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 |
![]() MDGL
Madrigal Pharmaceuticals, Inc. |
$310.25 | $6.85 B | -14.16 | 528 |
![]() NUVL
Nuvalent, Inc. |
$64.76 | $4.64 B | -16.48 | 142 |
![]() PLRX
Pliant Therapeutics, Inc. |
$1.25 | $76.55 M | -0.36 | 171 |
![]() STOK
Stoke Therapeutics, Inc. |
$6.00 | $317.80 M | -3.64 | 128 |
![]() TERN
Terns Pharmaceuticals, Inc. |
$2.00 | $174.60 M | -1.79 | 59 |
![]() VTYX
Ventyx Biosciences, Inc. |
$0.86 | $61.48 M | -0.44 | 79 |